Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Two novel radioligands, N,N-dimethyl-2-(2-amino-4-methoxyphenylthio) b enzylamine (DAPP) and (N,N-dimethyl-2-(2-amino-4-cyanophenylthio) benzylamine (D ASB), were radiolabeled with carbon-11 and evaluated as in vivo probes of the serotonin transporter (SERT) using positron emission tomography (PET). Both compounds are highly selective, with nanomolar affinity for the serotonin transporter and micromolar affinity for the dopamine and norepinephrine transporters. Six volunteers were imaged twice, once with each of the two radioligands. Both ligands displayed very good brain penetration and selective retention in regions rich in serotonin reuptake sites. Both had similar brain uptake and kinetics, but the cyano analogue, [11C]DASB, had a slightly higher brain penetration in all subjects. Plasma analysis revealed that both radiotracers were rapidly metabolized to give mainly hydrophilic species as determined by reverse-phase high-performance liquid chromatography. Inhibition of specific binding to the SERT was demonstrated in three additional subjects imaged with [11C]DASB following an oral dose of the selective serotonin reuptake blocker citalopram. These preliminary studies indicate that both these substituted phenylthiobenzylamines have highly suitable characteristics for probing the serotonin reuptake system with PET in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a total of 16 articles (reporting on 17 unique studies) were included [17–19, 28–40].”
From The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review (2022) · cites this paper as [34]
In the citing paper
“One study reported overall alcohol consumption during the study period [35], and seven studies controlled for present or past alcohol problems or abuse [17, 28, 30, 33, 34, 39, 40].”
From The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review (2022) · cites this paper as [34]
Citations
Cites
Wilson, A. A., Ginovart, N., Schmidt, M., Meyer, J. H., Threlkeld, P. G., & Houle, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000079i · Cited by 249
Self-citationRadiotracer synthesis from [11C]-iodomethane: a remarkably simple captive solvent method
Wilson, A. A., Garcia, A., Jin, L., & Houle, S. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00132-3 · Cited by 201
Self-citationSzabo, Z., Kao, P. F., Scheffel, U., Suehiro, M., Mathews, W. B., Ravert, H. T., Musachio, J. L., Marenco, S., Kim, S. E., Ricaurte, G. A., et al. (1995) · Synapse · doi:10.1002/syn.890200107 · Cited by 170
Laruelle, M., Vanisberg, M.-A., & Maloteaux, J.-M. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90198-9 · Cited by 166
High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue
Ba¨ckstro¨m, I., Bergstro¨m, M., & Marcusson, J. (1989) · Brain Research · doi:10.1016/0006-8993(89)90511-8 · Cited by 162
Wilson, A. A., & Houle, S. (1999) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/(sici)1099-1344(19991230)42:13<1277::aid-jlcr284>3.0.co;2-q · Cited by 71
Self-citationSmith, D. F. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00042-5 · Cited by 33
Acton, P. D., Kung, M., Mu, M., Plöessl, K., Hou, C., Siciliano, M., Oya, S., & Kung, H. F. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050459 · Cited by 33
Cited by
Items 101–200 of 299
Parsey, R. V., Ojha, A., Ogden, R. T., Erlandsson, K., Kumar, D. J. S., Landgrebe, M., Heertum, R. V., & Mann, J. J. (2006) · PubMed · Cited by 38
Lu, J. Q., Ichise, M., Liow, J. S., Ghose, S., Vines, D., & Innis, R. B. (2004) · PubMed · Cited by 39
Pharmacological MRI in animal models: A useful tool for 5-HT research?
Martin, C. J., & Sibson, N. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.014 · Cited by 42
“PET techniques have also been used to probe serotonin transporter function (e.g. Houle et al., 2000; Szabo et al., 1995) and serotonin synthesis (Nishizawa et al., 1997).”
Shiue, G. G., Fang, P., & Shiue, C. (2003) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00271-3 · Cited by 37
Emond, P., Vercouillie, J., Innis, R. B., Chalon, S., Mavel, S., FRANGIN, Y., Halldin, C., Besnard, J., & Guilloteau, D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010939a · Cited by 40
Neuroimaging Approaches in Mood Disorders: Technique and Clinical Implications
Konarski, J. Z., McIntyre, R. S., Soczynska, J. K., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653435 · Cited by 37
Hummerich, R., Reischl, G., Ehrlichmann, W., Machulla, H., Heinz, A., & Schloss, P. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02585.x · Cited by 36
“E-mail: schloss@zi-mannheim.de Abbreviations used: DA, dopamine; DASB, N,N-dimethyl-2-2-amino4-cyanophenylthiobenzylamine; DAT, dopamine transporter; NE, norepinephrine; NET, norepinephrine transporter; PET, positron emission tomography; SERT, serotonin transporter; SPECT, single photon emission computed tomography; S…”
BackgroundInfluentialMadsen, J. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00307-9 · Cited by 37
Zessin, J., Eskola, O., Brust, P., Bergman, J. R., Steinbach, J., Lehikoinen, P., Solin, O. H., & Johannsen, B. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00248-7 · Cited by 36
The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
Pagano, G., Niccolini, F., & Politis, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1823-7 · Cited by 35
“Taking these results into account, we suggest that SERT/ DAT ratios could be used as biomarker for LIDs and GIDs.”
BackgroundInfluentialNew-generation radiotracers for nAChR and NET
Ding, Y., & Fowler, J. S. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.04.017 · Cited by 34
Turkheimer, F., Selvaraj, S., Hinz, R., Murthy, V., Bhagwagar, Z., Grasby, P. M., Howes, O. D., Rosso, L., & Bose, S. K. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.108 · Cited by 34
“[11C]-DASB as an example: [11C]-DASB is a highly selective ligand for SERT, not only with nanomolar affinity for the SERT but also with micromolar affinity for the dopamine and norepinephrine transporters (Houle et al, 2000).”
BackgroundMethodStengler-Wenzke, K., Müller, U., Barthel, H., Angermeyer, M. C., Sabri, O., & Hesse, S. (2006) · Neuropsychobiology · doi:10.1159/000090702 · Cited by 34
Prange, S., Météreau, É., Maillet, A., Klinger, H., Schmitt, E., Lhommée, E., Bichon, A., Lancelot, S., Meoni, S., Broussolle, E., et al. (2022) · Movement Disorders · doi:10.1002/mds.28971 · Cited by 34
“We therefore decided to compare the longitudinal evolution of motor impairment and nonmotor neuropsychiatric symptoms up to 5 years after diagnosis in a cohort of de novo parkinsonian patients with or without apathy at diagnosis, associated with depressive and anxious symptoms, and to investigate their association wit…”
MethodEffects of Citalopram Infusion on the Serotonin Transporter Binding of [11C]DASB in Healthy Controls
Hinz, R., Selvaraj, S., Murthy, N. V., Bhagwagar, Z., Taylor, M., Cowen, P. J., & Grasby, P. M. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.41 · Cited by 32
“In correspondence with the known distribution of the SERT in human brain and as previously reported (Houle et al, 2000), high uptake of [11C]DASB was observed in thalamus, midbrain, and hypothalamus, moderate uptake in hippocampus and basal ganglia, and relatively low uptake in the cerebellum.”
BackgroundResultKomorowski, A., James, G. M., Philippe, C., Gryglewski, G., Bauer, A., Hienert, M., Spies, M., Kautzky, A., Vanicek, T., Hahn, A., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhw355 · Cited by 32
“[11C]DASB was used to quantify SERT (Houle et al. 2000; Ginovart et al. 2001; Meyer 2007) in 34 subjects (11 female, mean age = 31.3, SD = 9.7) according to previously described procedures (Haeusler et al. 2009; Savli et al. 2012).”
MethodInfluentialCarbon-11 HOMADAM: A novel PET radiotracer for imaging serotonin transporters
Jarkas, N., Votaw, J. R., Voll, R. J., Williams, L., Camp, V. M., Owens, M. J., Purselle, D. C., Bremner, J. D., Kilts, C. D., Nemeroff, C. B., et al. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.11.007 · Cited by 32
Brust, P., Zessin, J., Kuwabara, H., Pawelke, B., Kretzschmar, M., Hinz, R., Bergman, J., Eskola, O., Solin, O. H., Steinbach, J., et al. (2002) · Synapse · doi:10.1002/syn.10163 · Cited by 39
Nørgaard, M., Ganz, M., Svarer, C., Feng, L., Ichise, M., Lanzenberger, R. R., Lubberink, M., Parsey, R. V., Politis, M., Rabiner, E. A., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18770107 · Cited by 31
Nørgaard, M., Ganz, M., Svarer, C., Frøkjær, V. G., Greve, D. N., Strother, S. C., & Knudsen, G. M. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.05.055 · Cited by 31
“In this study, we extend the work of previous validation studies of the radioligand [ 11 C]DASB, which binds to the serotonin transporter (5-HTT), a target for many anti-depressive drugs (Houle et al., 2000; Meyer et al., 2001).”
ResultSerotonin regulation in a rat model of exercise-induced chronic fatigue
Liu, Z., Wu, Y., Liu, T., Li, R., & Xie, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.037 · Cited by 31
Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications
Haeusler, D., Mien, L., Nics, L., Ungersboeck, J., Philippe, C., Lanzenberger, R. R., Kletter, K., Dudczak, R., Mitterhauser, M., & Wadsak, W. (2009) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2009.03.005 · Cited by 31
Peng, C., Huang, Y.-Y., Huang, W.-S., & Shiue, C. (2007) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2007.11.009 · Cited by 30
Plisson, C., McConathy, J., Martarello, L., Malveaux, E., Camp, V. M., Williams, L., Votaw, J. R., & Goodman, M. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030384e · Cited by 29
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Pagano, G., Yousaf, T., & Politis, M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0794-2 · Cited by 31
Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease
Chou, K. L., Dayalu, P., Koeppe, R. A., Gilman, S., Spears, C. C., Albin, R. L., & Kotagal, V. (2022) · Movement Disorders · doi:10.1002/mds.29220 · Cited by 28
“…(DASB) is a positron emission tomography (PET) tracer that binds to the serotonin transporter (SERT) and can quantify regional serotoninergic projection terminal density 12-14 , providing an opportunity to examine rostral…”
In vivo Measurement of the Serotonin Transporter with (S)-([18F]fluoromethyl)-(+)-McN5652
Brust, P., Hinz, R., Kuwabara, H., Hesse, S., Zessin, J., Pawelke, B., Stephan, H., Bergmann, R., Steinbach, J., & Sabri, O. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300281 · Cited by 28
Frick, A., Åhs, F., Palmquist, Å. M., Pissiota, A., Wallenquist, U., Fernandez, M., Jonasson, M., Appel, L., Frans, Ö., Lubberink, M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.180 · Cited by 31
Imaging Markers of Progression in Parkinson's Disease
Strafella, A. P., Bohnen, N. I., Pavese, N., Vaillancourt, D. E., van Eimeren, T., Politis, M., Tessitore, A., Ghadery, C., Lewis, S. J. G., & on behalf of IPMDS‐Neuroimaging Study Group (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12673 · Cited by 35
“The serotonergic system is profoundly affected in PD, and PET ligands for the presynaptic serotonergic transporter (SERT), such as [(11)C]-DASB, are reliable tools to assess in vivo serotonergic terminals.(19) Previous work has demonstrated that the administration of L-dopa induces markedly higher striatal synaptic do…”
BackgroundLarsen, A. K., Brennum, L. T., Egebjerg, J., Sánchez, C., Halldin, C., & Andersen, P. H. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705693 · Cited by 28
“Four derivatives of this class of compounds, IDAM, ADAM, DASB and DAPP (Figure 1), have been found to have nanomolar to picomolar affinities for the SERT (Oya et al., 1999; Choi et al., 2000; Wilson et al., 2000).”
MethodInfluentialGeday, J., Hermansen, F., Rosenberg, R., & Smith, D. F. (2005) · Synapse · doi:10.1002/syn.20112 · Cited by 29
“Certain radiotracers are currently being used for studying some aspects of serotonin transport and receptor density (Brust et al., 1999; Houle et al., 2000; Meyer et al., 2001; Talbot and Laruelle, 2002).”
BackgroundLundquist, P., Roman, M., Syvänen, S., Hartvig, P., Blomquist, G., Hammarlund‐Udenaes, M., & Långström, B. (2007) · Synapse · doi:10.1002/syn.20382 · Cited by 34
Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies
Lundquist, P., Wilking, H., Höglund, A. U., Sandell, J., Bergström, M., Hartvig, P., & Långström, B. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.12.001 · Cited by 31
Wang, J. L., Parhi, A. K., Oya, S., Lieberman, B. P., Kung, M., & Kung, H. F. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.02.009 · Cited by 28
“Attempts to find improved PET tracers led to the development of 11C labeled DASB [17,18] (Table 1).”
BackgroundImaging neurochemical endophenotypes: promises and pitfalls
Martínez, D., Broft, A. I., & Laruelle, M. A. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.3.223 · Cited by 28
PET Neurochemical Imaging Modes
Placzek, M. S., Zhao, W., Wey, H., Morin, T., & Hooker, J. M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.09.001 · Cited by 31
Compartmental Modeling of11C-HOMADAM Binding to the Serotonin Transporter in the Healthy Human Brain
Nye, J. A., Votaw, J. R., Jarkas, N., Purselle, D. C., Camp, V. M., Bremner, J. D., Kilts, C. D., Nemeroff, C. B., & Goodman, M. M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.054262 · Cited by 26
Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity
Smith, D. F., & Jakobsen, S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00008 · Cited by 25
Serotonergic imaging in Parkinson's disease
de Natale, E. R., Wilson, H., & Politis, M. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2020.11.001 · Cited by 25
Rosso, L., Gee, A. D., & Gould, I. R. (2008) · Journal of Computational Chemistry · doi:10.1002/jcc.20972 · Cited by 25
Tuominen, L. J., Miettunen, J., Cannon, D. M., Drevets, W. C., Frøkjær, V. G., Hirvonen, J., Ichise, M., Jensen, P. S., Keltikangas‐Järvinen, L., Klaver, J. M., et al. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx071 · Cited by 31
“At the TPC, serotonin transporter binding was measured using [11C]MADAM (Lundberg et al., 2005) and personality traits using NEO-FFI (Costa and McCrae, 1992b), whereas other centers used [11C]DASB (Houle et al., 2000) and NEO-PI-R scale (Costa and McCrae, 1992a).”
MethodPET technology for drug development in psychiatry
Arakawa, R., Takano, A., & Halldin, C. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12084 · Cited by 26
Lin, K., Liu, C., Wey, S., Hsiao, I., Wu, J., Fu, Y.-K., & Yen, T. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.10.006 · Cited by 25
Karramkam, M., Dollé, F., Valette, H., Besret, L., Bramoullé, Y., Hinnen, F., Vaufrey, F., Franklin, C., Bourg, S., Coulon, C., et al. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00098-6 · Cited by 24
Huang, Y. H., Hwang, D., Zhu, Z., Bae, S., Guo, N., Sudo, Y., Kegeles, L. S., & Laruelle, M. A. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00337-2 · Cited by 24
S‐[18F]fluoromethyl‐(+)‐McN5652, a PET tracer for the serotonin transporter: Evaluation in rats
Marjamäki, P., Zessin, J., Eskola, O., Grönroos, T. J., Haaparanta‐Solin, M., Bergman, J., Lehikoinen, P., Forsback, S. J., Brust, P., Steinbach, J., et al. (2002) · Synapse · doi:10.1002/syn.10150 · Cited by 23
“…et al., 1999), phenyltropanes such as [11C]RTI-357 (Helfenbein et al., 1999), and the recently synthesized phenylthiobenzylamines [11C]DAPP, [11C]DASB (Houle et al., 2000; Wilson et al., 2000), and [11C]MADAM (Halldin et al., 2001; Tarkiainen et al., 2001) are promising new PET-tracers for SERT.”
Jarkas, N., McConathy, J., Voll, R. J., & Goodman, M. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050079o · Cited by 23
Sandell, J., Halldin, C., Sóvágó, J., Chou, Y.-H., Gulyás, B. Z., Yu, M., Emond, P., Någren, K., Guilloteau, D., & Farde, L. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00318-9 · Cited by 23
Jarkas, N., McConathy, J., Votaw, J. R., Voll, R. J., Malveaux, E., Camp, V. M., Williams, L., Goodman, R. R., Kilts, C. D., & Goodman, M. M. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.07.001 · Cited by 23
Neuroimaging of the serotonin reuptake site requires high‐affinity ligands
Elfving, B., Madsen, J., & Knudsen, G. M. (2007) · Synapse · doi:10.1002/syn.20443 · Cited by 22
“…both suitable for imaging of SERT in humans are at hand: [11C]N,N-dimethyl-2-2-amino-4-cyanophenylthiobenzylamine ([11C]DASB; Frankle et al., 2006; Houle et al., 2000; Kim et al., 2006; Meyer et al., 2001, 2004; Wilson et al., 2002) and [11C]N,N-dimethyl-2-(2amino-4-methylphenylthio)benzylamine…”
Stehouwer, J. S., & Goodman, M. M. (2009) · PET Clinics · doi:10.1016/j.cpet.2009.05.006 · Cited by 25
Neural network activation similarity: a new measure to assist decision making in chemical toxicology
Allen, T. E. H., Wedlake, A. J., Gelžinytė, E., Gong, C., Goodman, J. M., Gutsell, S., & Russell, P. J. (2020) · Chemical Science · doi:10.1039/d0sc01637c · Cited by 22
Huang, Y. H., Narendran, R., Bae, S., Erritzøe, D., Guo, N., Zhu, Z., Hwang, D., & Laruelle, M. A. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.03.010 · Cited by 21
Comley, R. A., Salinas, C. A., Slifstein, M., Petrone, M., Marzano, C., Bennacef, I., Shotbolt, P., van der Aart, J., Neve, M., Iavarone, L., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.202895 · Cited by 22
In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice
Walker, M., Ehrlichmann, W., Stahlschmidt, A., Pichler, B. J., & Fischer, K. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.163683 · Cited by 20
“One of the most promising noninvasive imaging approaches for visualizing the distribution of SERT is the SERT marker 11C-3amino-4(2-dimethylaminomethyl-phenylsufanyl)-benzonitrile (11CDASB), which is designed for PET (4).”
BackgroundMethodHirosawa, T., Kikuchi, M., Ouchi, Y., Takahashi, T., Yoshimura, Y., Kosaka, H., Furutani, N., Hiraishi, H., Fukai, M., Yokokura, M., et al. (2017) · Autism Research · doi:10.1002/aur.1761 · Cited by 21
Ogden, R. T., Zanderigo, F., & Parsey, R. V. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.12.038 · Cited by 22
“Such is the case for the serotonin transporter radioligand [(11)C]DASB (Wilson et al., 2000, 2002; Houle et al., 2000; Frankle et al., 2004) which can generally be modeled satisfactorily using a one tissue model (Ogden et al.”
Kretzschmar, M., Brust, P., Zessin, J., Cumming, P. D., Bergmann, R., & Johannsen, B. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00039-7 · Cited by 21
Jarkas, N., Voll, R. J., Williams, L., Votaw, J. R., Owens, M., & Goodman, M. M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0707929 · Cited by 20
Sandell, J., Yu, M., Emond, P., Garreau, L., Chalon, S., Någren, K., Guilloteau, D., & Halldin, C. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00787-4 · Cited by 20
Zhu, Z., Guo, N., Narendran, R., Erritzøe, D., Ekelund, J., Hwang, D., Bae, S., Laruelle, M. A., & Huang, Y. H. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.07.003 · Cited by 19
Neuroreceptor Imaging in Psychiatry: Theory and Applications
Frankle, W. G., Slifstein, M., Talbot, P. S., & Laruelle, M. A. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)67011-0 · Cited by 29
Risinger, R. C., Bhagwagar, Z., Luo, F. R., Cahir, M., Miler, L., Mendonza, A. E., Meyer, J. H., Zheng, M., & Hayes, W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3391-3 · Cited by 19
Self-citation[11C]‐NS 4194 versus [11C]‐DASB for PET imaging of serotonin transporters in living porcine brain
Jensen, S. B., Smith, D. F., Bender, D., Jakobsen, S., Peters, D., Nielsen, E. Ø., Olsen, G. M., Scheel‐Krüger, J., Wilson, A. A., & Cumming, P. D. (2003) · Synapse · doi:10.1002/syn.10222 · Cited by 18
“To test this hypothesis, we used PET to record the cerebral uptake and binding of [11C]-NS 4194, comparing its kinetics in vivo to those of a well-documented tracer for serotonin uptake sites, [11C]-DASB (Houle et al., 2000; Ginovart et al., 2001, 2003).”
BackgroundMethodSelf-citationThe serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites
Zeng, Z., Chen, T., Miller, P. J., Dean, D. A., Tang, Y. S., Sur, C., & Williams, D. L. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.02.007 · Cited by 18
as Serotonin Transporter Radioligands Under Various Experimental Conditions
Szabó, Z. R., McCann, U. D., Wilson, A. A., Scheffel, U., Owonikoko, T. K., Mathews, W. B., Ravert, H. T., Hilton, J., Dannals, R. F., & Ricaurte, G. A. (2002) · Cited by 18
Self-citationSlifstein, M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046631 · Cited by 17
“Eventually, several additional ligands that are much more highly selective for serotonin transporters became available for imaging humans, including trans-1,2,3,5,6,10-b-hexahydro 6-[4-(methylthio)phenyl]pyrrolo-[2,1-a]isoquinoline (11C-McNeil 5652) (11) and 11C-N,N-dimethyl-2-(2-amino-4cyanophenylthio)-benzylamine (1…”
BackgroundRegional Differences in Serotonin Transporter Occupancy by Escitalopram: An [11C]DASB PK-PD Study
Kim, E., Howes, O. D., Kim, B.-H., Chon, M.-W., Seo, S., Turkheimer, F. E., Lee, J. S., Lee, Y.-S., & Kwon, J. S. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0444-x · Cited by 15
11C-labeling and preliminary evaluation of vortioxetine as a PET radioligand
Andersen, V. L., Hansen, H. D., Herth, M. M., Knudsen, G. M., & Kristensen, J. L. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.044 · Cited by 16
Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands
Ganz, M., Feng, L., Hansen, H. D., Beliveau, V., Svarer, C., Knudsen, G. M., & Greve, D. N. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16686092 · Cited by 17
Thiele, F. O., & Buchert, R. (2008) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3282f28138 · Cited by 17
3D QSAR of Serotonin Transporter Ligands: CoMFA and CoMSIA Studies
Wellsow, J., Machulla, H., & Kovar, K. (2002) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.200290000 · Cited by 16
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors
Fu, H., Rong, J., Chen, Z., Zhou, J., Collier, T. L., & Liang, S. H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00633 · Cited by 19
Fukai, M., Hirosawa, T., Kikuchi, M., Ouchi, Y., Takahashi, T., Yoshimura, Y., Miyagishi, Y., Kosaka, H., Yokokura, M., Yoshikawa, E., et al. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.06.015 · Cited by 15
Babenko, V. N., Смагин, Д. А., Kovalenko, I. L., Galyamina, A. G., & Kudryavtseva, N. N. (2020) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-019-00888-9 · Cited by 14
“…2000; Huang et al., 2002; Meyer, 2007; for review see Kristensen et al., 2011] led to the development of highly selective radioactive methods – in vivo indicators used for positron emission tomography and single-photon emission computerized tomography [Houle et al., 2000; Wilson et al., 2000].”
MethodMarthi, K., Jakobsen, S., Bender, D., Hansen, S., Smith, S., Hermansen, F., Rosenberg, R., & Smith, D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1754-x · Cited by 16
“PET neuroimaging has provided procedures for investigating some aspects of neurotransmission in the living human brain (Grasby 1999; Houle et al. 2000; Laruelle 2000; Halldin et al. 2001; Talbot and Laruelle 2002), but many aspects of antidepressant actions remain unexplored, partly due to relatively high non-specific…”
BackgroundLi, Q., Ma, L., Innis, R. B., Seneca, N. M., Ichise, M., Huang, Y. H., Laruelle, M. A., & Murphy, D. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058636 · Cited by 15
Reisinger, S. N., Wanek, T., Langer, O., & Pollak, D. D. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0416-7 · Cited by 15
Occupancy of serotonin transporter by tramadol: a positron emission tomography study with [11C]DASB
Ogawa, K., Tateno, A., Arakawa, R., Sakayori, T., Ikeda, Y., Suzuki, H., & Okubo, Y. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001764 · Cited by 14
“Thalamus has the highest specific binding of 5-HTT (Houle et al., 2000).”
Nørgaard, M., Ganz, M., Svarer, C., Frøkjær, V. G., Greve, D. N., Strother, S. C., & Knudsen, G. M. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19880450 · Cited by 17
“All participants were scanned in a Siemens ECAT HRRT scanner with the selective 5-HTT radioligand [(11)C]DASB.(22) The protocol consisted of a 90-min dynamic acquisition (3D list-mode) post injection of 587 30 (mean SD) MBq bolus into an elbow vein.”
MethodSmall Molecules as Radiopharmaceutical Vectors
Gee, A. D., Bongarzone, S., & Wilson, A. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-98947-1_7 · Cited by 13
Self-citationRadiotracer development in psychiatry
Pimlott, S. L. (2005) · Nuclear Medicine Communications · doi:10.1097/00006231-200503000-00002 · Cited by 13
Macoveanu, J., Fisher, P. M., Madsen, M. K., Mahon, B. M., Knudsen, G. M., & Siebner, H. R. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.06.024 · Cited by 12
Veronese, M., Gunn, R. N., Zamuner, S., & Bertoldo, A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.10.048 · Cited by 12
“DASB is a PET radioligand labelled with carbon-11 that enables quantification of the serotonin transporter in the brain (Houle et al., 2000).”
BackgroundDaniel, R. B., Deuther‐Conrad, W., Scheunemann, M., Steinbach, J., Brust, P., & Mishani, E. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.006 · Cited by 12
Evaluation of [11C]metergoline as a PET radiotracer for 5HTR in nonhuman primates
Hooker, J. M., Kim, S. W., Reibel, A. T., Alexoff, D. L., Xu, Y., & Shea, C. E. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.039 · Cited by 12
Positron emission tomography radiochemistry
Mason, N. S., & Mathis, C. A. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00093-5 · Cited by 16
Neurochemical Imaging and Depressive Behaviours
Meyer, J. H. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_219 · Cited by 14
“…a major advance due to its high selectivity, reversibility, greater specific binding relative to free and non-specific binding and reliability (Ginovart et al. 2001; Houle et al. 2000; Ichise et al. 2003; Meyer et al. 2001b, 2004a, b; Praschak-Rieder et al. 2005; Wilson et al. 2000, 2002).”
BackgroundSelf-citationMavel, S., Méheux, N., Guilloteau, D., & Emond, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.062 · Cited by 11
Lee, J., Kim, B., Kim, E., Howes, O. D., Cho, K. I. K., Yoon, Y. B., & Kwon, J. S. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2642 · Cited by 11
Bois, F., Baldwin, R. M., Amici, L., Al‐Tikriti, M. S., Kula, N. S., Baldessarini, R. J., Innis, R. B., Staley, J. K., & Tamagnan, G. D. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.09.002 · Cited by 11
Bruzzone, S. E. P., Ozenne, B., Fisher, P. M., Ortega, G., Jensen, P. S., Dam, V. H., Svarer, C., Knudsen, G. M., Lesch, K., & Frøkjær, V. G. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01678-y · Cited by 12
“PET imaging allows quantification of serotonin system protein levels in the living brain [33, 34].”
BackgroundTakano, A., Suhara, T., Sudo, Y., Inoue, M., Hashimoto, K., Zhang, M., Ichimiya, T., Yasuno, F., & Suzuki, K. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0884-4 · Cited by 10
Martín, A., Szczupak, B., Gómez‐Vallejo, V., Plaza, S., Padró, D., Cano, A., & Llop, J. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.156 · Cited by 10
A Probabilistic Approach to Delineating Functional Brain Regions
Kalbitzer, J., Svarer, C., Frøkjær, V. G., Erritzøe, D., Baaré, W. F. C., Madsen, J., Hasselbalch, S. G., & Knudsen, G. M. (2009) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.108.054056 · Cited by 10
“Quantification and Region Assessment The radioligand 11C-DASB binds with high affinity and selectivity to 5-HTT sites (11).”
BackgroundMavel, S., Vercouillie, J., Garreau, L., Raguza, T., Ravna, A. W., Chalon, S., Guilloteau, D., & Emond, P. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.002 · Cited by 10
Clinical translation of neuroimaging research in mood disorders.
Konarski, J. Z., McIntyre, R. S., Soczynska, J. K., Bottas, A., & Kennedy, S. H. (2006) · PubMed Central · Cited by 11
Reductive Amination with [11C]Formaldehyde: A Versatile Approach to Radiomethylation of Amines
Wu, C., Li, R., Dearborn, D. G., & Wang, Y. (2012) · International Journal of Organic Chemistry · doi:10.4236/ijoc.2012.23030 · Cited by 9
Jarkas, N., Voll, R. J., Williams, L., & Goodman, M. M. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.03.004 · Cited by 9
“Based on the phenylthiophenyl core structure of ADAM, a large collection of C-11 [22–24] and F-18 [7,25–27] labeled diphenylsulfides, substituted on rings A and/or B, has been synthesized and evaluated as PET SERT imaging agents.”
BackgroundQuinlivan, M., Mattner, F., Papazian, V., Zhou, J., Katsifis, A. G., Emond, P., Chalon, S., Kozikowski, A. P., Guilloteau, D., & Kassiou, M. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(03)00076-3 · Cited by 9
Metadata
- Authors
- Houle, S., Ginovart, N., Hussey, D., Meyer, J. H., & Wilson, A. A.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Houle, S.
- Venue
- European Journal of Nuclear Medicine
- Published
- 2000-09-23
- Volume
- 27
- Issue
- 11
- Pages
- 1719-1722
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2169396775
- Cited by
- 276
- References
- 8
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 14 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 13 · 2013: 7 · 2012: 11
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- serotonin transporter, [11C]DASB, serotonin uptake, neuroimaging, radiotracer metabolism, citalopram, dopamine transporter, norepinephrine transporter, brain penetration
- MeSH terms
- Adult, Benzylamines, Carbon Radioisotopes, Carrier Proteins, Female, Humans, Male, Membrane Glycoproteins, Middle Aged, Nerve Tissue Proteins, Tomography, Emission-Computed, Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.